TCGX Stock News & Catalysts

FEATURED

TriGemX Bio Appoints Daniel Lynch as Chairman of the TriGemX Bio Board of Directors

New

TriGemX Bio, Inc. ("TriGemX Bio"), a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (NASDAQ:TCGX) ("TCGX"), a

Summary

Nov 9, 2026, 7:00 AM ·Business Wire

RECENT

TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination

TriGemX Bio, Inc. ("TriGemX Bio"), a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (NASDAQ:TCGX) ("TCGX"), a

Nov 2, 2026, 6:00 AM ·Business Wire

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine

Transaction Includes Concurrent $160 million Private Investment in Public Equity (PIPE) Financing and Expected Gross Proceeds of Approximately $246 million TriGemX Bio, a biotechnology company focused on developing

Oct 19, 2026, 7:00 AM ·Business Wire

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine

Oct 19, 2026, 7:00 AM ·Business Wire

TCGX Acquisition Corp. Announces Completion of its Initial Public Offering

TCGX Acquisition Corp. (the "Company") announced today the closing of its initial public offering of 8,625,000 Class A ordinary shares at a price of $10.00 per share, including the 1,125,000 shares issued

Aug 6, 2026, 4:05 PM ·Business Wire

TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering

TCGX Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. Unlike certain other special purpose

Aug 4, 2026, 7:10 PM ·Business Wire

TCGX Acquisition Corp. Class A Ordinary Shares TCGX · News